Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Rita
Contact Rita, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck RackActions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Articles
DNA and mRNA vaccines: Significant therapeutic approach against cancer management
Cancer is among the most challenging cancers to fight, mostly because of its variety and complexity. Different types of cancer have distinct characteristics that render an approach that is universally applicable ineffective. The heterogeneity of tumors, in which various cells in the same tumor display distinct phenotypic and genetic profiles can make treatment more difficult (Chakraborty & Rahman, 2012a).
Key considerations for hMSC product and process development through clinical cGMP manufacturing
Jan Nolta Professor, Director of the Stem Cell Program and Gene Therapy Center at University of California, Davis Jan A. Nolta, Ph.D., is the Director of the Stem Cell Program at University of California Davis School of Medicine and directs the Institute for Regenerative Cures and the new UC Davis Gene Therapy Center. She also serves as the Scientific Director of the large UC Davis Good Manufacturing Practice Facility, and as PI of the California State Umbilical Cord Blood Collection Program.
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Rita
Contact Rita, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack